{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:17Z","timestamp":1786119557845,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,2]]},"DOI":"10.1097\/qad.0b013e32833f9d02","type":"journal-article","created":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T13:16:50Z","timestamp":1285334210000},"page":"37-47","source":"Crossref","is-referenced-by-count":40,"title":["European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142*"],"prefix":"10.1097","volume":"25","author":[{"given":"Todd","family":"Hulgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Haubrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A","family":"Riddler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Tebas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylyn D","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A","family":"McComsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A","family":"Canter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1073\/pnas.91.19.8739","article-title":"Mitochondrial DNA sequence variation in human evolution and disease","volume":"91","author":"Wallace","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s004390100602","article-title":"Association of the mitochondrial DNA 5178 A\/C polymorphism with serum lipid levels in the Japanese population","volume":"109","author":"Kokaze","year":"2001","journal-title":"Hum Genet"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1529-8817.2005.00192.x","article-title":"The association of mitochondrial DNA 5178 C > a polymorphism with plasma lipid levels among three ethnic groups","volume":"69","author":"Lal","year":"2005","journal-title":"Ann Hum Genet"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1253\/circj.67.16","article-title":"Mitochondrial 5178A\/C genotype is associated with acute myocardial infarction","volume":"67","author":"Mukae","year":"2003","journal-title":"Circ J"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s00125-008-0933-z","article-title":"A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians","volume":"51","author":"Park","year":"2008","journal-title":"Diabetologia"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.aids.0000216367.23325.58","article-title":"Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis","volume":"20","author":"Lewis","year":"2006","journal-title":"AIDS"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/labinvest.3780288","article-title":"Mitochondrial DNA depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors","volume":"81","author":"Lewis","year":"2001","journal-title":"Lab Invest"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.aids.0000180786.02930.a1","article-title":"Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study","volume":"19","author":"Hulgan","year":"2005","journal-title":"AIDS"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1086\/652419","article-title":"African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.","volume":"201","author":"Canter","year":"2010","journal-title":"J Infect Dis"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1086\/528697","article-title":"Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy","volume":"197","author":"Hulgan","year":"2008","journal-title":"J Infect Dis"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/QAI.0b013e3181a324d6","article-title":"Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy","volume":"51","author":"Hendrickson","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591706","article-title":"Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy","volume":"47","author":"Nasi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMoa074609","article-title":"Class-sparing regimens for initial treatment of HIV-1 infection","volume":"358","author":"Riddler","year":"2008","journal-title":"N Engl J Med"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","article-title":"Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment","volume":"23","author":"Haubrich","year":"2009","journal-title":"AIDS"},{"key":"R17-5-20210130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1310\/MUQC-QXBC-8118-BPM5","article-title":"A multiinvestigator\/institutional DNA bank for AIDS-related human genetic studies: AACTG protocol A5128","volume":"4","author":"Haas","year":"2003","journal-title":"HIV Clin Trials"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/genetics\/144.4.1835","article-title":"Classification of European mtDNAs from an analysis of three European populations","volume":"144","author":"Torroni","year":"1996","journal-title":"Genetics"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/FPC.0b013e32814db8b7","article-title":"Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy","volume":"17","author":"Arnedo","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pmed.0030052","article-title":"Associations among race\/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy","volume":"3","author":"Foulkes","year":"2006","journal-title":"PLoS Med"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/00002030-200210180-00005","article-title":"TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy","volume":"16","author":"Maher","year":"2002","journal-title":"AIDS"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00002030-200301030-00017","article-title":"Tumour necrosis factor-alpha gene -238G\/A promoter polymorphism associated with a more rapid onset of lipodystrophy","volume":"17","author":"Nolan","year":"2003","journal-title":"AIDS"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/QAD.0b013e32830a9886","article-title":"Genetic analysis implicates resistin in HIV lipodystrophy","volume":"22","author":"Ranade","year":"2008","journal-title":"AIDS"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/429295","article-title":"Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders","volume":"191","author":"Tarr","year":"2005","journal-title":"J Infect Dis"},{"key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1158\/0008-5472.CAN-05-1428","article-title":"Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women","volume":"65","author":"Canter","year":"2005","journal-title":"Cancer Res"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MCO.0b013e3282f0b774","article-title":"Lessons that can be learned from patients with diabetogenic mutations in mitochondrial DNA: implications for common type 2 diabetes","volume":"10","author":"Maassen","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","article-title":"Role of mitochondrial dysfunction in insulin resistance","volume":"102","author":"Kim","year":"2008","journal-title":"Circ Res"},{"key":"R28-5-20210130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/01.RES.0000258450.44413.96","article-title":"Mitochondrial dysfunction in atherosclerosis","volume":"100","author":"Madamanchi","year":"2007","journal-title":"Circ Res"},{"key":"R29-5-20210130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2004.03.008","article-title":"Association of a 5178C\u2013>A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals","volume":"175","author":"Takagi","year":"2004","journal-title":"Atherosclerosis"},{"key":"R30-5-20210130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00439-003-0983-8","article-title":"Association of the mitochondrial DNA 15497G\/A polymorphism with obesity in a middle-aged and elderly Japanese population","volume":"113","author":"Okura","year":"2003","journal-title":"Hum Genet"},{"key":"R31-5-20210130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s001250050866","article-title":"A common mitochondrial DNA variant is associated with insulin resistance in adult life","volume":"41","author":"Poulton","year":"1998","journal-title":"Diabetologia"},{"key":"R32-5-20210130","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/hmg\/11.13.1581","article-title":"Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study","volume":"11","author":"Poulton","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R33-5-20210130","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1469-1809.2005.00249.x","article-title":"The European-specific mitochondrial cluster J\/T could confer an increased risk of insulin-resistance and type 2 diabetes: an analysis of the m.4216T > C and m.4917A > G variants","volume":"70","author":"Crispim","year":"2006","journal-title":"Ann Hum Genet"},{"key":"R34-5-20210130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.diabres.2006.05.007","article-title":"Role of the mitochondrial m.16189T>C variant in type 2 diabetes mellitus in southern Brazil","volume":"74","author":"Crispim","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"R35-5-20210130","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1136\/jmg.2007.048876","article-title":"Mitochondrial DNA haplogroups and type 2 diabetes: a study of 897 cases and 1010 controls","volume":"44","author":"Chinnery","year":"2007","journal-title":"J Med Genet"},{"key":"R36-5-20210130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1086\/504926","article-title":"Comprehensive association testing of common mitochondrial DNA variation in metabolic disease","volume":"79","author":"Saxena","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R37-5-20210130","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1161\/CIRCULATIONAHA.107.756809","article-title":"Mitochondrial haplogroups: ischemic cardiovascular disease, other diseases, mortality, and longevity in the general population","volume":"117","author":"Benn","year":"2008","journal-title":"Circulation"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e32833f9d02","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:26Z","timestamp":1786041326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201101020-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833f9d02","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,2]]}}}